Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer. [electronic resource]
Producer: 20100319Description: 1344-9 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Drug Resistance, Neoplasm
- Female
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Recurrence
- Retreatment
- Small Cell Lung Carcinoma -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.